Aarhus C, Denmark

Henrik Pedersen

USPTO Granted Patents = 17 

Average Co-Inventor Count = 1.2

ph-index = 6

Forward Citations = 112(Granted Patents)


Location History:

  • Aarhus, DK (2020)
  • Aarhus C, DK (2017 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Inventor Profile: Henrik Pedersen

Introduction

Henrik Pedersen, an accomplished inventor based in Aarhus C, Denmark, has made significant contributions to the field of biotechnology, particularly in the area of complement system modulation. With a remarkable portfolio of 17 patents, he has shaped innovative solutions aimed at treating disorders related to the complement system.

Latest Patents

Henrik's latest patents include groundbreaking inventions such as "Bispecific Constructs for Target and Complement Engagement." In this patent, he provides single domain antibodies capable of specifically binding to epitopes of human complement factors, including C1q, C3, and C4, as well as their proteolytic derivatives C3b and C4b. Additionally, he outlines methods for modulating the activity of the complement system, offering potential treatments for various complement-mediated diseases.

Another notable patent is titled "Methods of Treating Complement-Mediated Disease," where Henrik also presents single domain antibodies designed for specific binding to human complement factors, Cq, C3, and C4. This innovation enhances approaches for modulating complement system activity, thereby providing new avenues for treating disorders associated with complement activation.

Career Highlights

Throughout his career, Henrik has worked with esteemed organizations such as Gloster Furniture Limited and Aarhus Universitet. His work at these institutions highlights his commitment to advancing research in biotechnology and his drive to translate scientific discoveries into practical applications.

Collaborations

Henrik has collaborated with talented individuals like Nick Stub Laursen and Dennis Vestergaard Pedersen. These partnerships have facilitated knowledge exchange and propelled innovative research, ultimately benefiting the scientific community and the development of new therapeutic strategies.

Conclusion

Henrik Pedersen represents a dynamic force in the world of biotechnology. His extensive patent portfolio and collaborative efforts reflect his dedication to addressing complex medical challenges through innovation. As advancements in his specialized field continue, the impact of his work on treating complement-mediated diseases holds great promise for improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…